DE60116474D1 - Hcv ns2/3 fragmente und ihre verwendungen - Google Patents

Hcv ns2/3 fragmente und ihre verwendungen

Info

Publication number
DE60116474D1
DE60116474D1 DE60116474T DE60116474T DE60116474D1 DE 60116474 D1 DE60116474 D1 DE 60116474D1 DE 60116474 T DE60116474 T DE 60116474T DE 60116474 T DE60116474 T DE 60116474T DE 60116474 D1 DE60116474 D1 DE 60116474D1
Authority
DE
Germany
Prior art keywords
hcv
fragments
renatured
modulators
assays
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60116474T
Other languages
English (en)
Other versions
DE60116474T2 (de
Inventor
Irbm P Angeletti Steinkuhler
Irbm P Angeletti Pallaoro
Ist Ric Biol Molecolare P Lahm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Original Assignee
Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto di Ricerche di Biologia Molecolare P Angeletti SpA filed Critical Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Application granted granted Critical
Publication of DE60116474D1 publication Critical patent/DE60116474D1/de
Publication of DE60116474T2 publication Critical patent/DE60116474T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Hydrogenated Pyridines (AREA)
  • Detergent Compositions (AREA)
DE60116474T 2000-03-17 2001-03-14 Hcv ns2/3 fragmente und ihre verwendungen Expired - Fee Related DE60116474T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0006537 2000-03-17
GBGB0006537.5A GB0006537D0 (en) 2000-03-17 2000-03-17 Assays and screening methods
PCT/IB2001/000527 WO2001068818A2 (en) 2000-03-17 2001-03-14 Hcv ns2/3 fragments and uses thereof

Publications (2)

Publication Number Publication Date
DE60116474D1 true DE60116474D1 (de) 2006-03-30
DE60116474T2 DE60116474T2 (de) 2006-09-07

Family

ID=9887885

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60116474T Expired - Fee Related DE60116474T2 (de) 2000-03-17 2001-03-14 Hcv ns2/3 fragmente und ihre verwendungen

Country Status (10)

Country Link
US (1) US7078215B2 (de)
EP (1) EP1278867B1 (de)
JP (1) JP2003526361A (de)
AT (1) ATE315093T1 (de)
AU (1) AU4269401A (de)
CA (1) CA2403405A1 (de)
DE (1) DE60116474T2 (de)
ES (1) ES2254380T3 (de)
GB (1) GB0006537D0 (de)
WO (1) WO2001068818A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2430661C (en) 2000-12-15 2010-10-19 Boehringer Ingelheim (Canada) Ltd. Purified active hcv ns2/3 protease
ATE322506T1 (de) * 2004-01-19 2006-04-15 Ares Trading Sa Verfahren zur reinigung von in bakterien exprimierten proteinen
US20090233266A1 (en) * 2005-03-10 2009-09-17 The Rockefeller University Structure of the hepatitis c virus ns2 protein
JP2009513113A (ja) * 2005-10-28 2009-04-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃ型肝炎ウイルスｎｓ２／３活性のアッセイ法
EP2388312A1 (de) 2010-05-17 2011-11-23 Curetis AG Universell anwendbarer Lysepuffer und Verarbeitungsverfahren zur Lyse von Körperproben

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888762A (en) * 1990-06-05 1999-03-30 Centre National De La Recherche Scientifique (Cnrs) Neurotropic growth factors comprising a homeobox peptide
IT1277914B1 (it) * 1995-08-22 1997-11-12 Angeletti P Ist Richerche Bio Procedimento per produrre - in forma pura e in quantita' elevate - polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e
US5837464A (en) * 1996-01-29 1998-11-17 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US6242187B1 (en) * 1996-01-29 2001-06-05 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US6280940B1 (en) * 1998-08-05 2001-08-28 Agouron Pharmaceuticals, Inc. Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease
WO2001016379A1 (en) * 1999-08-30 2001-03-08 Merck & Co., Inc. Hepatitis c virus replication inhibitors
CA2430661C (en) * 2000-12-15 2010-10-19 Boehringer Ingelheim (Canada) Ltd. Purified active hcv ns2/3 protease

Also Published As

Publication number Publication date
CA2403405A1 (en) 2001-09-20
US7078215B2 (en) 2006-07-18
GB0006537D0 (en) 2000-05-10
EP1278867A2 (de) 2003-01-29
US20040054134A1 (en) 2004-03-18
ES2254380T3 (es) 2006-06-16
ATE315093T1 (de) 2006-02-15
WO2001068818A3 (en) 2002-03-21
EP1278867B1 (de) 2006-01-04
JP2003526361A (ja) 2003-09-09
WO2001068818A2 (en) 2001-09-20
AU4269401A (en) 2001-09-24
DE60116474T2 (de) 2006-09-07

Similar Documents

Publication Publication Date Title
ATE212037T1 (de) Inhibitoren von serinproteasen, insbesondere von ns3-protease des hepatitis-c-virus
DK1268847T3 (da) Ubiquitin-ligaseassay
UY27972A1 (es) Derivados de hidantoína
ATE421973T1 (de) Inzektizide proteinen von bacillus thuringiensis
DE60111534D1 (de) Alpha-acyl- und alpha-heteroatom-substituierte benzenacetamide verwendbar als glucokinase-aktivatoren
DE69825904D1 (de) Mutante alpha-amylase mit zusätzlicher disulfidverbindung
DE60326259D1 (de) Neue fructosylpeptidoxidase und deren nutzung
ATE280163T1 (de) Substituierte phenylacetamide und ihre verwendung als glukokinase aktivatoren
IT1272179B (it) Metodologia per riprodurre in vitro l'attivita' proteolitica della proteasi ns3 del virus hcv.
BR0215405A (pt) Composições e processos de uso de collajolie
DE60144145D1 (de) Subtilisin-variante
DE69914792D1 (de) Tragbares telefon und einschaltverfahren
NO20053595L (no) Escitalopramdibromid samt fremgangsmate ved fremstilling derav.
ID27198A (id) Anhidrat dan monohidrat n-(3-etunilfenilamino)-6,7-bis (2-metoksietoksi)-4-kuinazolinamina mesilat
DE60138140D1 (de) Acyl- und sulfonylderivative 6,9-disubstitutierter 2-(trans-1,4-diaminocyclohexyl)-purine und ihre verwendung als antiproliferative mittel
DE60009888D1 (de) Substituierte 3-cyano-[1.7], [1.5] und [1.8]naphthyridininhibitoren von tyrosin kinasen
ID30417A (id) Popok sekali pakai dan proses pembuatannya
NO20031860L (no) Kahalalid F
DE60116474D1 (de) Hcv ns2/3 fragmente und ihre verwendungen
DE68915112T2 (de) Spiro-isochinolin-pyrrolidin-tetrone und Analoge davon, verwendbar als Aldosereduktase-Inhibitoren.
ATE253059T1 (de) Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2- one und ihre verwendung als lipase-hemmer
BR0213278B1 (pt) composição vedante e seu uso.
ATE326520T1 (de) Teilchen für flüssige zubereitungen
PT929299E (pt) 1,2,3,4-tetra-hidro-2-dibenzofuranaminas e 2-aminociclo-hepta ¬b| benzofuranos substituidos
TR200002939T2 (tr) Paroksetin maleat

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee